# A Study to Compare ORMD-0801 Once Daily to ORMD-0801 Three Times Daily in Subjects With Type 1 Diabetes

> **NCT04150107** · PHASE2 · COMPLETED · sponsor: **Oramed, Ltd.** · enrollment: 30 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DRUG:** ORMD-0801 Treatment A
- **DRUG:** ORMD-0801 Treatment B
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04150107
- **Lead sponsor:** Oramed, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-17
- **Primary completion:** 2020-02-06
- **Final completion:** 2020-03-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-06-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04150107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04150107, "A Study to Compare ORMD-0801 Once Daily to ORMD-0801 Three Times Daily in Subjects With Type 1 Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04150107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*